Results 131 to 140 of about 10,598 (216)

Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy. [PDF]

J Pathol Clin Res
Yakoub MA, Sukhadia P, Saoud C, Hameed M, Antonescu CR.   +4 more
europepmc   +1 more source

Age stratifies disease extent in pediatric and young adult fusion-positive papillary thyroid carcinoma. [PDF]

J Endocr Soc
Canberk S, Baloch ZW, Carillo AM, Isaza A, Barros R, Bojarsky M, Bauer AJ.   +6 more
europepmc   +1 more source

Real-World Evidence for Oncology Patients With Rare <i>NTRK</i> Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRK. [PDF]

JCO Precis Oncol
Potthoff K, Lange S, Seufferlein T, Heinrich K, Claus R, Bleckmann A, Zaiss M, Vannier C, Grebhardt S, Koszinowski S, Hillebrand LE, Ringwald K, Kasenda B.   +12 more
europepmc   +1 more source

RBPMS::NTRK3-rearranged sacral malignant spindle cell tumor in neurofibromatosis diagnosed by RNA sequencing: a case report and literature review. [PDF]

Front Med (Lausanne)
Chen C, Qi B, Miao Y, Zhuang Z, Wang C, Dai W.   +5 more
europepmc   +1 more source

NTRK Family Gene Mutation [PDF]

, 2020
openaire   +1 more source

<i>NTRK</i>-positive collision tumor of the gastrointestinal tract: a rare entity case report. [PDF]

Ann Med Surg (Lond)
Sirek A, Amann VC, Uzun S, Bubendorf L, Rosenberg R, Burri E, Häuptle P, Roma L, Mertz KD.   +8 more
europepmc   +1 more source

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC). [PDF]

Cureus
Gainor J, Popat S, Bundy L.
europepmc   +1 more source

Real-World Outcomes of Fusion-Directed Targeted Therapy in Advanced Non-Small Cell Lung Cancer Harboring Actionable Gene Fusions. [PDF]

Int J Mol Sci
Delgado Leon F, de Armas SA, Molina M, Morales EG, Fernandez-Gomez M, Raez LE.   +5 more
europepmc   +1 more source

OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor [PDF]

Neuro-Oncology, 2017
P. K. Brastianos, C. Alvarez-Breckenridge, J. J. Miller, N. Nayyar, C. Gill, D. Dias-Santagata, S. Santagata, P. Multani, S. Yip, D. Cahill, A. J. Iafrate, T. Batchelor   +11 more
openaire   +1 more source

Infant-Type Hemispheric Glioma With NTRK Fusion Responds to Larotrectinib. [PDF]

Cureus
Jain PV, Rumler S, North P.
europepmc   +1 more source